Global antibiotics market set to grow to USD 72.01 billion by 2033, driven by various factors.

From GlobeNewswire: 2024-06-19 16:00:00

The global antibiotics market is set to grow from USD 48.2 billion in 2023 to USD 72.01 billion by 2033, with a CAGR of 4.10%. Antibiotics inhibit bacterial growth and treat infections. Factors driving market growth include rising infectious diseases, aging population, and increased demand for antibiotics. However, challenges such as antibiotic resistance and regulatory requirements hinder market expansion.

The cell wall segment is expected to dominate the global antibiotics market, with cell wall synthesis inhibitors being widely used and effective in treating bacterial infections. Cephalosporins show the fastest CAGR growth. Generics are estimated to hold the largest market share due to accessibility and affordability. Respiratory infections are predicted to have the highest market share, with online pharmacies dominating distribution channels.

North America is projected to lead the global antibiotics market due to high government healthcare spending. Meanwhile, Asia Pacific is expected to grow the fastest, driven by increased healthcare infrastructure and prevalence of infectious diseases. Key players in the market include Pfizer, Novartis, and Sanofi. Recent developments include Orchid Pharma receiving approval to market its antibiotic in Europe and Baxter International launching a new injection.

The study forecasts revenue globally, regionally, and at country levels from 2023 to 2033. Segments include action mechanism, drug class, type, application, and distribution channel. Regions covered are North America, Europe, Asia Pacific, South America, and Middle East & Africa. Market analysis includes key players, product offerings, business overviews, SWOT analysis, and recent developments in the global antibiotics market.



Read more at GlobeNewswire: Global Antibiotics Market Size To Worth USD 72.01 Billion